Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial

FH Messerli, GL Bakris, RD Ferrera… - … Hypertension, 2006 - Wiley Online Library
The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia. …

Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia

JN Cohn, DJ Wilson, J Neutel… - … of hypertension, 2009 - academic.oup.com
… safety of coadministered amlodipine and atorvastatin in hypertensive patients with dyslipidemia.
The AWC substudy assessed the effects of coadministered amlodipine and atorvastatin …

… , and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial

RA Preston, P Harvey, O Herfert… - The Journal of …, 2007 - Wiley Online Library
… that the coadministration of amlodipine and atorvastatin across the dose ranges for both
treatments is efficacious and safe in patients with hypertension and dyslipidemia. Importantly, …

Efficacy and safety of coadministered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia

X Jin, MH Kim, KH Han, SJ Hong… - … Hypertension, 2020 - Wiley Online Library
… patients with hypertension and dyslipidemia. … amlodipine plus rosuvastatin versus telmisartan
plus rosuvastatin or telmisartan/amlodipine in patients with hypertension and dyslipidemia

Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia

K McKeage, MAA Siddiqui - American journal of cardiovascular drugs, 2008 - Springer
… of amlodipine and atorvastatin in the prevention of CVD and in the treatment of patients with
hypertension and dyslipidemia, … with the coadministration of amlodipine and atorvastatin in …

Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients

G Derosa, P Maffioli - Expert Review of Cardiovascular Therapy, 2010 - Taylor & Francis
… reductions with amlodipine 5 mg or coadministered amlodipine 5 mg … hypertension and
dyslipidemia, the single-pill amlodipine plus … Control of hypertension and dyslipidemia had been …

Single‐pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study)

R Blank, J LaSalle, R Reeves, J Maroni… - … Hypertension, 2005 - Wiley Online Library
… The coadministration of amlodipine and atorvastatin has been demonstrated to be safe and
… in patients with concomitant hypertension and dyslipidemia. The rationale for the Amlodipine/…

P-241 MP-30: Safety and tolerability of coadministered amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia in the respond study

RA Preston, F Sun, L Tarasenko - … Journal of Hypertension, 2005 - search.proquest.com
… with concomitant HTN/DYS. Furthermore, AEs observed with coadministered amlodipine
plus atorvastatin are similar in nature, severity, and frequency to those seen with amlodipine

[PDF][PDF] Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia

S Bashir, MUIK Sherwani, I Shabbir… - Journal of Ayub …, 2011 - demo.ayubmed.edu.pk
… and atorvastatin in patients with hypertension and dyslipidemia: results of the … of coadministered
amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia

P-413: The efficacy and safety of fixed-dose combinations of amlodipine and atorvastatin in the treatment of patients with concomitant hypertension and dyslipidemia

RA Preston, P Harvey, O Herfert… - … Journal of Hypertension, 2004 - search.proquest.com
… efficacy of amlodipine. … Coadministration of amlodipine and atorvastatin is efficacious at
reducing SBP and LDL-C levels and safe when administered to patients with concomitant HTN